Business Context and Reporting Period
This Form 8-K, dated February 28, 2022, reports a material definitive agreement entered into by Healthcare Trust of America, Inc. (the "Company") and Healthcare Realty Trust Incorporated ("HR"). The filing announces a merger agreement under which HR will merge with a subsidiary of the Company. Upon closing, the Company will change its name to Healthcare Realty Trust Incorporated and trade on the NYSE under the ticker symbol "HR".
Key Financial Metrics and Transaction Terms
The filing details the financial structure of the proposed merger rather than historical operating results for the period.
- Exchange Ratio: Each outstanding share of HR Common Stock will be converted into 1.000 share of Company Class A Common Stock.
- Special Distribution: Holders of Company Common Stock will receive a special cash distribution of $4.82 per share.
- Financing Commitment: The Company has secured a fully underwritten financing commitment from JPMorgan Chase Bank, N.A., for up to $1.7 billion in debt financing to fund the Special Distribution if proceeds from joint ventures and asset sales are insufficient.
- Termination Fees:
- HR to pay Company: $163 million (plus up to $5 million in transaction expenses) under specific termination scenarios.
- Company to pay HR: $291 million under specific termination scenarios.
- Expense Reimbursement: $25 million fixed base plus up to $5 million in actual expenses if the deal fails due to stockholder vote rejection after the other party's approval.
Note: The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels for either entity as of the reporting date.
Material Changes and Transaction Structure
The primary material change is the execution of the Merger Agreement. Key structural elements include:
- Corporate Governance: The post-merger board will consist of 13 members: nine from HR and four designated by the Company. John Knox Singleton (HR Chairman) will become Chairman of the combined board, and W. Bradley Blair II (Company Chairman) will become Vice Chairman.
- Stock Awards: HR stock options and restricted stock will be assumed by the Company and converted to Company Common Stock based on the 1:1 exchange ratio. Company restricted shares subject to performance vesting will vest in full prior to the effective time.
- Funding Strategy: The Special Distribution is expected to be funded by a combination of capital from newly formed joint ventures, asset sales, and the committed debt financing.
Guidance, Outlook, Risks, and Contingencies
Outlook and Conditions: The transaction is intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. Closing is subject to customary conditions, including stockholder approval from both companies, effectiveness of the Form S-4, NYSE listing approval, and the absence of material adverse effects.
Risks and Contingencies:
- Financing Risk: The $1.7 billion debt commitment is subject to customary conditions; failure to secure financing could trigger termination fees.
- Termination Triggers: The agreement may be terminated if not consummated by August 28, 2022 (the "Outside Date"), if stockholders reject the deal, or if a superior proposal is accepted (subject to termination fees).
- Operational Risks: Risks include diversion of management attention, integration difficulties, failure to realize expected benefits, and general economic or real estate market downturns.
- Forward-Looking Statements: The filing includes standard disclaimers regarding the uncertainty of future results, financing availability, and the ability to complete the transaction on the anticipated timeline.
Important Facts for Investor Verification
- Verify the final terms of the $1.7 billion debt financing commitment and any conditions precedent to drawing funds.
- Confirm the status of stockholder approvals required from both Healthcare Trust of America and Healthcare Realty Trust.
- Review the upcoming Form S-4 and joint proxy statement for detailed financial data, risk factors, and the full text of the Merger Agreement.
- Monitor the progress of asset sales and joint venture formations intended to fund the $4.82 per share special distribution.
- Check for any regulatory approvals or injunctions that could delay or prevent the closing before the August 28, 2022 Outside Date.